Formulation with Cyclodextrins

Velesco is a niche CRO specializing in early phase drug development.  On of our core competencies is formulation of compounds for early toxicology studies.  We take a targeted, scientific approach to formulation.

 

One of our tools for formulation of poorly soluble early stage compounds is the family of Cyclodextrins.

 

Download our Free whitepaper describing Cyclodextrins and how they can be used as early stage solubilizers.

 

Considerations-in-using-CD-for-early-drug-development-2013.pdf

News and Events

Velesco CEO Dave Barnes will attend the Global Clinical Supplies Group meeting in April.

 

Dave Barnes Featured in Pharmoutsourcing article!

 

 

Follow VelescoPharma on Twitter  LinkedIn IN Icon 25px
aaps logo TN

734-527-9125